Impact of diagnostics on antimicrobial prescribing
Monday, July 12, 2021
5. New antibacterial agents, PK/PD & Stewardship, 1-hour Oral Session
•
S16
•
10:45 AM
>
11:45 AM
•
Impact of diagnostics on antimicrobial prescribing
•
5. Antimicrobials & stewardship
10:45 AM
•
14
•
Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of <em>Pseudomonas aeruginosa</em> infections: an observational study in a university hospital
>
A.
Aline
MUNTING (Lausanne)
10:55 AM
•
294
•
Transition to molecular-based diagnosis of stool pathogens: diagnostic stewardship and antibiotic consumption
>
D.
David
SHASHA (Ramat Gan)
11:05 AM
•
1736
•
A diagnostic randomised controlled trial to study the impact of rapid diagnostic tests in patients with acute febrile illness when compared to conventional diagnostics (DRACO study)
>
N.
Nitin
GUPTA (Udupi)
11:15 AM
•
4133
•
Colonisation-guided approach to empirical therapy and antimicrobial stewardship in allogeneic haematopoietic stem cell transplantation (allo HSCT)
>
M.
Marina
POPOVA (Saint Petersburg)
11:25 AM
•
178
•
Understanding prescribers' beliefs about molecular diagnostic tests as barriers and facilitators to test uptake in intensive care units (ICUs): a qualitative study
>
A.
Alyssa Megan
PANDOLFO (London)
11:35 AM
•
INT81
•
Q&A/Discussion
|